Potential thiamine deficiency in elderly patients with gastrointestinal cancer undergoing chemotherapy .
Potential thiamine deficiency in elderly patients with gastrointestinal cancer undergoing chemotherapy . Int J Clin Pharmacol Ther. 2020 Jan 27;: Authors: Yasu T, Iimura Y, Momo K, Kuroda S Abstract Gastrointestinal cancer and its treatment using fluorouracil-based anticancer agents are risk factors for thiamine deficiency (TD). Therefore, we aimed to determine the prevalence of TD among elderly patients with gastrointestinal cancer undergoing chemotherapy. We retrospectively reviewed the medical records of 12 elderly patients with gastrointestinal cancers who underwent chemotherapy. Median serum thiamine level was 22.5 ng/mL (range, 17 - 42 ng/mL). Four patients (33.3%) exhibited TD (
Dalton Trans., 2020, Accepted Manuscript DOI: 10.1039/D0DT01882A, PerspectiveJian-Qiang Liu, Yuyu Zhong, Xiaosan Li, Junhao Chen, XiaoXiong Wang, LIntao Wei, Liqing Fang, Abhinav Kumar, Shuze Zhuang Still today, cancer remains intimidating to human health. The possible common treatments to cure this disease includes chemotherapy(CT), radiotherapy(RT), photothermal therapy (PTT) and surgical resection which give unreasonable results because... The content of this RSS Feed (c) The Royal Society of Chemistry
Condition: Metastatic Colorectal Cancer Interventions: Drug: CPGJ602; Drug: cetuximab Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. Not yet recruiting
Condition: Non-Myeloid Malignancy Interventions: Drug: YPEG-rhG-CSF; Drug: rhG-CSF/PEG-rhG-CSF Sponsors: Xiamen Amoytop Biotech Co., Ltd.; Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting
Authors: Hussain T, Mattheis S, Lang S Abstract The incidence of human papillomavirus (HPV)-positive oropharyngeal carcinomas is increasing worldwide. Due to a markedly different response to treatment compared to HPV-negative oropharyngeal carcinomas, determining the ideal therapeutic approach can be challenging. Particularly in never-smokers, HPV-positive oropharyngeal carcinomas respond well to primary radiation therapy; at the same time recent studies indicate comparable survival after primary surgery. For stage I tumors according to TNM‑8, retrospective analyses show very good oncologic outcomes aft...
How safe and effective are these two agents for controlling chemotherapy-induced nausea and vomiting in patients with cancer?Chinese Clinical Oncology
This study is aimed to explore the role of a stable perfusion temperature in promoting bowel recovery of PC patients due to gastrointestinal malignancies. METHODS: Between January 2012 and July 2013, 59 PC patients undergoing cytoreductive surgery and three-cycle HIPEC were included. Patients having stable perfusion temperature for all cycles were assigned into the study group, with the rest having unstable temperature into the control group. Time of flatus and defecation passage and initiation time of enteral nutrition were compared between both groups to detect the significance in bowel function recovery, with visua...
Cancer patients are a population at high risk of contracting COVID-19 and, also of developing severe complications due to the infection, which is especially true when they are undergoing immunosuppressive treatment. Despite this, they had still to go to hospital to receive chemotherapy during lockdown. In this context, we have evaluated the psychological status of onco-hematological outpatients receiving infusion and not deferrable anti-neoplastic treatment for lymphoproliferative neoplasms, with the aim of both measuring the levels of post-traumatic symptoms, depression, and anxiety during the pandemic and also of investi...
Condition: Breast Cancer Intervention: Drug: Vitamin C, Vitamin E Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Recruiting
Condition: Triple Negative Breast Cancer Interventions: Drug: Ipatasertib; Drug: Capecitabine; Drug: Eribulin; Drug: Carboplatin; Drug: Gemcitabine Sponsors: MedSIR; Hoffmann-La Roche Not yet recruiting
Condition: Endometrial Cancer Interventions: Drug: retifanlimab; Drug: epacadostat; Drug: pemigatinib Sponsors: Incyte Corporation; Gynecologic Oncology Group; European Network for Gynaecological Oncological Trial groups(ENGOT) Not yet recruiting